Karnataka is developing a dedicated support framework for its biotechnology sector, encompassing funding, mentoring, and regulatory guidanc...

The most impactful AI products of 2026 aren't built to do everything; they're built to solve one problem exceptionally well. The ET Most In...

Chemists must now have a doctor's prescription to sell cough syrups. The government has changed the Drugs Rules, 1945. This stops over-the-...

The lawsuit seeks a court order directing the platform, which is owned by ByteDance, to make changes to bring it into compliance with the l...

Rising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...

A new drug for Alzheimer's, donanemab, has arrived in India. It aims to slow the disease's progression by clearing brain plaques. While off...

Marking the 29th anniversary of the Uphaar cinema fire tragedy, the Association of Victims of Uphaar Tragedy (AVUT) on Saturday intensified...

India has taken a bold step by deregulating key radio frequencies, paving the way for innovative advancements in self-driving and collision...

India's telecom department has removed licensing for 5.9 GHz and 77-81 GHz spectrum bands. This move will enhance passenger safety in vehic...

Baidu's self-driving service, AmiGo, has gained regulatory approval in Switzerland. This joint venture with PostBus plans to launch Europe'...

The Central Information Commission has criticized the Petroleum and Natural Gas Regulatory Board. This is for not properly answering a Righ...

Several states have constituted dedicated multi-member teams to ensure no facility slips through the cracks before a GMP Certificate is iss...

AstraZeneca Pharma India has secured approval from India's drug regulator for its smart chemotherapy drug Enhertu. This allows for its impo...

As artificial intelligence grows more powerful, governments must move beyond transparency measures and introduce stronger regulations to ad...

The landscape of India's anti-obesity drug market has reached a point of refinement. While there are affordable generic options, their upta...

India's drug regulator, CDSCO, has mandated all drug companies to establish systems for tracking adverse drug reactions. This move comes am...

The Delhi High Court has asked the Central Drugs Standard Control Organisation to review a petition challenging Zydus Lifesciences' approva...